|Day Low/High||4.55 / 5.21|
|52 Wk Low/High||3.10 / 11.93|
The names include a veterinary drug concern plus companies with successful drugs on the market.
Aratana Therapeutics and Kindred Biosciences are promising drug developers in the pet space.
We've made a few tweaks due to price changes, while others were based on a last-minute assessment of better value.
The second half of our value-stocks portfolio for the New Year.
Even if the markets were to take a dive, the strength of our holdings will prevail.
These 3 names may not draw attention, but they can draw profits.
A group of seven to 15 securities, if carefully selected, can provide all the diversification an investor needs.
Brexit has caused active investors to flee and created an opportunity for those who are patient.
Sometimes, the under-research companies offer the biggest opportunities.
Investors should see this selection as one part of a multi-year investment program.
My Winning Value Portfolio didn't live up to its name in 2015.
August was a month to forget, dragged down by the energy names.
Despite portfolio performance, valuations of most of the stocks appear to be as compelling as ever.
Only Chenier Energy was a winner among these 10 names.
A weak March showing isn't catastrophic, but be ready for more pain.
When the Fed knocks down certain market sectors, we value investors know what to do.